Growing demand for sophisticated and personalized treatment options to cure liver metastasis is expected to boost the market.Rockville, MD, Dec. 10, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a ...
News Medical on MSN12d
Extracellular vesicle DNA regulates immune responses and suppresses liver metastasisThe study highlights how EV-DNA packaging influences immune responses and its promise as a biomarker for assessing colorectal ...
MCCLEAN, VA, UNITED STATES, December 16, 2024 /EINPresswire / -- Perthera, the leader in AI-driven Precision Oncology Decision Support, has unveile ...
About Zetagen Therapeutics Founded in 2015, Zetagen Therapeutics is a private, clinical-stage, biopharmaceutical company ...
It uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line treatments have ...
Patients with heavily pretreated microsatellite stable metastatic colorectal cancer (CRC) had survival benefits after using ...
Contrary to expectations, higher levels of this EV-DNA reduced liver metastasis risks in pancreatic and colorectal cancers.
On the morning of December 12, 2024 (UTC-6), at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San ...
From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.
Ensartinib has received FDA approval for the first-line treatment of anaplastic lymphoma kinase (ALK)-positive locally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback